Pediatric Endocrinology — Specialty Profile

Subspecialty fellowship of Pediatrics.

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: peds endo, pediatric endocrinology. A fellowship you enter after a pediatrics residency, rather than a specialty you match into straight from medical school. Organ systems: the endocrine axes of growth, puberty, thyroid, adrenal, pituitary, and bone and mineral, plus the metabolic disease of childhood, above all diabetes.

The 30-second version

Pediatric endocrinology is the specialty of hormones, growth, and metabolism in children, the doctors who manage a kid's type 1 diabetes for a decade, figure out why a 12-year-old isn't growing, work up early or late puberty, and steer thyroid, adrenal, and metabolic-bone disease. It is almost entirely an outpatient, cognitive, longitudinal field: you reason through the body's feedback loops, titrate therapy, teach families, and follow the same children for years, sometimes from toddlerhood into young adulthood. There are essentially no procedures. That single fact shapes everything downstream, including the field's defining paradox: it is one of the very few paths in medicine where three extra years of training can leave you earning near a general pediatrician, or even below one.12

Quick dashboard (details and sources below)
Training after med school Peds residency (3) + Peds Endocrinology fellowship (3) = 6 yrs after med school
Total from college start ~14 years (4 undergrad + 4 med school + 3 residency + 3 fellowship)
Competitiveness (as a peds subspecialty) Low / very accessible — chronically underfills (~48% of fellowship slots filled, 2026) ⟳
Typical full-time pay $230,426 (Survey · Doximity 2025, 2024 earnings) — the lowest specialty line in that report ⟳
Pay range (structure) No percentiles are published openly. MGMA and AMGA carry a pediatric endocrinology line and sell it; nothing free reports a spread ⟳
Lifestyle Predominantly outpatient, clinic-hours, minimal overnight call, telehealth-friendly
Burnout Drivers are systemic (pay, admin, understaffing) rather than acuity. No subspecialty row on either survey; this page reads the general-pediatrics proxy at ~51% (Medscape 2024, 49% average) over adult endocrinology at ~44%, because the economics are pediatric ⟳
% women 77.8% of fellows (ACGME, AY2024-25) — among the most female peds subspecialties ⟳
DO / IMG accessibility Comparatively open — ~36% of 2026 applicants were non-US-MD; field openly relies on IMGs ⟳

What they actually do

Pediatric endocrinologists diagnose and manage hormonal and metabolic disorders in children and teens: type 1 and type 2 diabetes, growth disorders and short stature, early or delayed puberty, thyroid disease, adrenal and pituitary conditions, obesity and metabolic disease, bone and mineral metabolism, and differences/disorders of sex development (DSD).3 The work is overwhelmingly outpatient and cognitive: reasoning through the endocrine axes and their feedback loops, ordering and interpreting stimulation tests, and titrating therapy over months and years. Because so many endocrine conditions are chronic, the emotional and clinical core of the job is continuity: you follow the same children and families for years, teaching and coaching as much as prescribing.3

There is essentially no procedural revenue stream: no OR, no scopes, no cath lab. Income is entirely evaluation-and-management (E&M) and RVU-based, which is the structural reason the field sits at the bottom of the physician pay distribution (see Compensation).1 The daily texture is diagnostic puzzles plus a heavy longitudinal panel: growth-hormone and insulin management, device data review, and a steady administrative tail of refills, prior authorizations, and between-visit messaging.4

Representative work (cognitive, not procedural): diabetes management with continuous glucose monitors (CGMs), insulin pumps, and closed-loop "automated insulin delivery" systems · growth-hormone stimulation testing and therapy · puberty evaluation and suppression/induction · thyroid function workups and nodule/cancer surveillance · adrenal disorders including congenital adrenal hyperplasia · pituitary disease · obesity/metabolic management (increasingly including GLP-1 receptor agonists in adolescents) · multidisciplinary DSD and newborn "ambiguous genitalia" evaluations.35

A day in the life: mostly a clinic day. Back-to-back scheduled visits (a new-onset diabetes teach, a short-stature workup, a puberty consult, a thyroid follow-up, an obesity or metabolic visit) interleaved with reviewing CGM and pump downloads, answering the inbox, and fighting prior authorizations for growth hormone and newer obesity drugs.4 Emergencies are relatively few and mostly diabetic (DKA, new-onset diabetes admissions); call is largely phone/consult call for the inpatient team rather than being pulled in at 2 a.m. to operate.35

The training path & time to completion

Medical school (4 yrs) → Pediatrics residency (3 yrs) → Pediatric Endocrinology fellowship (3 yrs) → board-eligible with the American Board of Pediatrics (ABP).6 This is a two-step entry: you do not match into pediatric endocrinology out of medical school. You first match into (and complete) a categorical pediatrics residency, and only then apply to fellowship through the NRMP Pediatric Specialties Match (Specialties Matching Service), held in the fall for appointments beginning the following July.6

  • Fellowship is 3 years. Longer than the 2-year length of some other pediatric subspecialties, and it carries a substantial scholarly/research requirement. Workforce literature repeatedly cites that extra length as a deterrent given the field's near-absent pay premium.67
  • Board: the ABP subspecialty certificate in Pediatric Endocrinology; candidates must first hold general pediatrics certification. (Pediatric endocrinology became the 5th ABP subboard, in 1978.)6
  • Total from the start of college: ~14 years (4 undergrad + 4 med school + 3 residency + 3 fellowship); 10 years from the start of medical school.6

How competitive is it?

Here the usual framing flips. As a pediatric subspecialty, pediatric endocrinology is not competitive in the selectivity sense, but chronically underfilled. The constraint is too few applicants rather than too many.

In the 2026 Pediatric Specialties Match, pediatric endocrinology offered 106 positions across 64 programs and filled only 51, a 48.1% fill rate with 55 slots unfilled. There were only ~56 applicants of all types for those 106 positions, an applicant-to-position ratio of roughly 0.53 : 1, meaning nearly twice as many training slots as people applying.6 ⟳

What that means for you:

  • A committed pediatrics resident who wants pediatric endocrinology is very likely to match. It is one of the more attainable fellowships to enter.6
  • This is structural, not a one-year blip. Endocrinology is repeatedly named among the chronically unfilled pediatric fellowships. Across all 17 pediatric subspecialties in the same appointment-year-2026 match, 1,542 of 1,969 positions filled, a rate of 78.3%; endocrinology sits thirty points below that, alongside pediatric nephrology, while the better-filled peds subspecialties ran ~96–99% (cardiology, gastroenterology).68 ⟳
  • The honest read: the wide-open door is the visible symptom of a documented workforce shortage, and low compensation relative to training length is the driver most often blamed for it.79 The same softness that makes the field accessible is a real signal about the pay structure you'd graduate into (see Compensation and the FLI angle).

Compensation — the robust version

This is where pediatric endocrinology is genuinely unusual, and it deserves to be named squarely and without euphemism.

The headline paradox. Pediatric endocrinology requires three extra years of fellowship after residency, yet frequently earns the same as a general pediatrician or less, and is routinely cited as the single lowest-paid physician specialty in the United States.12 The clearest single data point, from the Doximity 2025 report (2024 data): pediatric endocrinology averaged $230,426, the lowest of any specialty listed, against $265,230 for general pediatrics, roughly $35,000 less despite the extra training. (For scale, the top specialty in the same report, neurosurgery, earned $749,140.)1 ⟳

Why the paradox exists (consistent across sources): it is a purely cognitive/E&M field with no procedures to bill, and compensation is RVU-driven. Pediatric endocrinologists generate only ~65% of the work RVUs of adult endocrinologists and earn roughly 79% of adult-endocrinology pay ($230,426 against $290,606, Doximity 2025); in academic settings specifically, peer-reviewed data show median pediatric-endocrinology salary falling below that of a general pediatrician.1 Low Medicaid reimbursement (pediatrics covers a large share of publicly insured children), long counseling-heavy visits, and the structural underpayment of cognitive care all compress it further.1 MedMoneyGuide's 2026 pediatrician salary guide, an aggregator rather than a survey, summarizes it bluntly: the fellowship adds two to three years of training for "zero to negative financial return" relative to general pediatrics.2 The framing has become organized advocacy, with pediatric subspecialists banding together under the banner "More Training to Earn Less."9

National number. One survey publishes this field, and everything below rests on it. Doximity's 2025 report, on 2024 earnings, gives pediatric endocrinology $230,426, the lowest specialty line in the report.1 It is an average rather than a median, it is self-reported, and it is not adjusted for inflation. ⟳

This page used to set three aggregator figures alongside that one and split the difference at $240,000–$255,000. Those hosts are excluded under this site's compensation sourcing standard, so the aggregate is gone rather than downgraded, and the surveyed figure now stands alone at about $10,000 to $25,000 below where this page used to put the field.101112

The spread. Nobody publishes one openly. MGMA and AMGA both maintain a discrete pediatric endocrinology category and sell the percentiles inside subscription benchmark reports, and outside those, no society, no peer-reviewed study and no freely readable survey reports percentiles, a starting-versus-experienced curve, or a state-by-state breakdown for the field.10 This page no longer carries the ones it used to, because their only support was aggregator sites. That absence is worth taking at face value rather than filling: it means the honest answer to "what will I actually be offered" is that you will have to ask people doing the job, and the field's own workforce literature is unusually willing to talk about pay.

Academic vs. private, which is the split that matters here. Academic and freestanding-children's-hospital employment dominates the field, because low procedural revenue makes independent practice hard to sustain.1 AMSPDC's 2023 commentary on academic pediatric subspecialist pay reports its whole picture as ratios to the adult counterpart rather than as dollars, and puts academic pediatric endocrinology at 90% of adult endocrinology, level with pediatric rheumatology and infectious disease; pediatric gastroenterology is lowest at 70%, and child psychiatry, pediatric anesthesia and pediatric surgery all come out above their adult counterparts.13 Read that against the 79% the national survey gives and you are watching two instruments disagree, which is what happens when one measures academic faculty benchmarks and the other measures everybody. The same paper supplies the mechanism underneath both: an academic pediatric endocrinologist's annual work-RVU benchmark is 65% of the adult endocrinologist's, and in a compensation system built on RVUs that is most of the story.13 The upside of the academic and nonprofit concentration is real for borrowers, because it makes PSLF genuinely achievable (see FLI angle).

How you're actually paid. Salary or wRVU-based E&M compensation, with no procedural fees. Because income is cognitive-visit-based, there's little of the "pick up shifts to scale earnings" lever that hourly specialties have, and that is as much a constraint on the ceiling as the base rate is.

The trend that colors all of it. Demand is rising sharply: type 1 and especially type 2 diabetes are climbing with childhood obesity, and FDA-approved adolescent GLP-1 agonists (semaglutide, liraglutide) are expanding visit volume, against a shrinking workforce.57 But because that growth is cognitive management rather than procedures, it does not fundamentally change the low-RVU pay structure. Pay is essentially flat; Medscape 2026 reports pediatrics remains the lowest-paying specialty, with ~47% of pediatricians expecting flat pay and only 45% feeling fairly compensated.14 One faint bright spot: the pediatric-vs-adult endocrinology gap narrowed in 2024, from 34% the year before to about 26%, partly credited to rising childhood obesity and adolescent GLP-1 use.1 Read that 26% carefully, because it is the gap measured from the pediatric end: adult endocrinology pays 26% more than pediatric, and pediatric pays 21% less than adult. Same two numbers, and the direction you measure from changes the figure by five points. ⟳

Lifestyle & the outpatient bargain

The most-cited pro of pediatric endocrinology is its controllability. It is predominantly outpatient and clinic-hours, with no OR duties and no procedures that pull you in overnight.3 Call exists but is largely phone and consult call: inpatient DKA and new-onset diabetes, plus consults for hypoglycemia, adrenal crisis, electrolyte/calcium disturbances, and newborn DSD evaluations, much of it handled remotely or by protocol with the inpatient team.3 The schedule is predictable, plannable, and compatible with family life and part-time arrangements, and the field is notably telehealth-friendly: diabetes management, growth monitoring, medication titration, and device (CGM/pump) review map well to virtual visits, and endocrinology broadly has been a leader in sustained post-pandemic telehealth.15

The most-cited con is the quiet one: the administrative tail. The trade-off for a controllable schedule is a heavy longitudinal panel: refills, prior authorizations (especially growth hormone and newer obesity/GLP-1 drugs), device downloads, and between-visit messaging. The work is steady rather than intense, but the inbox is real.4

Lifestyle rating: 4/5. High schedule control and predictability, minimal overnight call, and part-time/telehealth compatibility, with the caveat of a documentation/inbox load and the understaffing pressure that comes with a shortage field.

Wellbeing — the part to take seriously

Satisfaction is generally high, and it's driven by meaning rather than money. Practicing pediatric endocrinologists describe the work as intellectually satisfying, with "treatable disorders" grounded in logical physiology and "challenging thinking and rewarding outcomes."3 This page used to put career-satisfaction and would-choose-again percentages here. They came from a self-selected panel of 25 on an excluded aggregator, and they are gone with the pay figures from the same source; no independent satisfaction survey of this subspecialty was found. The emotional core is long-term relationships: because the conditions are chronic, you build deep continuity with children and families over years, and many in the field say that continuity is exactly why they'd choose it again.3 ⟳

Career longevity is a genuine strength. No procedural physical demands, no hospital nights, no shift-work circadian disruption. This is a specialty you can sustain across a full career and into later life, including part-time. It's a common landing spot for physicians who want to practice for decades without burning out physically.3

Burnout drivers here are systemic, not clinical. The dominant stressors are compensation relative to training length, administrative burden (prior auths, inbox), and understaffing (too many patients for too few endocrinologists in many regions), rather than acuity or trauma.4 Cross-specialty benchmarks put pediatrics broadly around 51% burnout and adult endocrinology around 44% (Medscape 2024), useful context given pediatric endocrinology isn't always broken out separately.16 The field-specific signal is telling: in one 2025 analysis of pediatricians, 87% felt their compensation was insufficient for the complexity of their work, 69% had considered a career change, and 65% had modified their practice (higher volume, reduced staffing).14 The through-line is a workforce that largely loves the clinical work but is worn down by the economics around it.

Those two benchmarks are seven points apart, so which one carries the page matters. It reads general pediatrics at 51%, against Medscape's own 49% all-physician average, because the stressors named just above are the pediatric-workforce pattern: pay set against a three-year fellowship, a Medicaid-weighted payer mix, and clinics staffed too thin for the referral volume. Adult endocrinology shares the shape of the day, an outpatient cognitive clinic with no nights and no procedures, and it does not share the economics, which is the part doing the damage here. AMA publishes no row for either parent in its 2025 Organizational Biopsy, so both figures come from Medscape because it is the only instrument that measures them.16 ⟳

Who's in the field (demographics)

  • Women: heavily majority, and the fellowship is counted directly. ACGME puts pediatric endocrinology at 196 women of 252 active fellows, 77.8%, in academic year 2024-25, above the Pediatrics residency's own 74.8% and seventh of the seventeen pediatrics subspecialty rows in the same table.17 ⟳ The adult field is trending the same way, though the figures usually quoted for it are a decade old and belong to adult endocrinology rather than this subspecialty: ≈72% of entering endocrinology fellows were women in 2013 and ~75% of applicants in 2014, with the field projected to become female-predominant.1819
  • IMG: a real and substantial entry point. The field openly relies on international medical graduates to staff fellowship slots; among 2026 match applicants, ~36% were non-US-MD, and a recent fellow survey found ~25% said visa considerations influenced their job opportunities, an indirect marker of heavy IMG representation.67 Exact current % of the certified workforce lives in the ABP dashboard. ⟳
  • DO: comparatively accessible. Because positions far exceed applicants, the field is relatively open to DOs (bundled with IMGs in the ~36% non-US-MD applicant share, 2026).6 ⟳
  • URiM: no reliable pediatric-endocrinology-specific figure was confirmable from primary sources; peds subspecialties broadly report low URiM representation (single-digit to low-double-digit for Black and Hispanic/Latino physicians), and endocrinology isn't documented as an exception.7 ⟳ (limited data)

Culture, personality & the online stereotypes

Who gravitates here: people who find endocrine physiology genuinely beautiful, meaning the feedback loops, the axes, and the logic of titration, and who'd rather reason through a diagnostic puzzle than do a procedure. It draws patient teachers and long-game relationship builders energized by educating kids and parents and watching a child grow up under their care; people who explicitly weight lifestyle, control, and meaning over maximum income; and clinicians drawn specifically to type 1 diabetes and its fast-evolving technology (CGMs, closed-loop systems). As always, plenty of people in the field do not fit any single mold.35

The stereotypes. community perceptions, not facts. Each with a humanizing counterpoint:

  • "Fellowship into a pay cut, the lowest ROI in medicine." The pay disparity is real (see FLI). But it reflects a broken reimbursement system that undervalues cognitive pediatric care, rather than the value of the work or the ability of the people who do it. Many practitioners find the trade fully worth it.5
  • "It's all diabetes and growth charts." The scope actually spans DSD, bone/metabolic disease, adrenal and pituitary disorders, thyroid cancer surveillance, gender-related care, and a fast-moving obesity and metabolic frontier, plus some of the most rapidly advancing technology in all of pediatrics.5
  • "Lifestyle and meaning, but poorly paid, a consolation prize." Partly true on pay, but framing it as a consolation misses that many actively want the outpatient, longitudinal, family-centered life this field offers. For them it's the goal, not a compromise.5

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums, a recurring "pay paradox" debate keeps resurfacing, and students openly weigh that peds endo can pay less than general pediatrics despite three extra fellowship years, against their loan debt. Some call it the field's central deterrent; others counter that the lifestyle, job security, and love of the work outweigh the delta. There's strong consensus that the fellowship is very accessible (programs regularly underfill), read by some as a warning sign, by others as an opportunity for those who genuinely want it. People acknowledge the workforce shortage and geographic maldistribution (long clinic waits, easy job market), which fuels a recurring "why does something so needed pay so little?" thread. And those who chose it tend to defend it warmly, citing continuity with families, controllable hours, and intellectual satisfaction, while advising anyone chasing income to look elsewhere.20

Voices from the field. Paraphrased from public writing, with links to the originals:

  • Abraham Kim, writing in Doximity's Op-Med, reports pediatric subspecialists earn far less than adult counterparts across the board, with the peds-vs-adult endocrinology gap narrowing to ~26% in 2024 (from 34%), partly on rising childhood obesity and adolescent GLP-1 use, while general pediatricians' inflation-adjusted income has actually fallen since 2017.1
  • Pam Georgiana, in Pediatrics Nationwide (summarizing Dr. Nahata's workforce research), describes fellows hoping to spend ~61% of their time on clinical care but new hires landing at ~75%, squeezing out research and education; only 6% of job-seekers found research-focused roles; and a dual crisis of clinical shortage plus a shrinking physician-scientist pipeline, with proposed fixes including better subspecialty pay and federal loan repayment.7
  • Medscape's "More Training to Earn Less" captures the field's defining tension in its title: extra fellowship training that can yield lower pay than general pediatrics, motivating subspecialists to organize around reimbursement and workforce reform.9
  • KevinMD contributors writing on childhood type 1 diabetes emphasize the stakes and rewards of early detection and management, the mission-driven, prevention-and-education ethos that draws many into pediatric diabetes care.21

Why people choose it / why people leave

Why choose it: you love physiology and diagnostic reasoning and want a cognitive, non-procedural field · a controllable, predominantly outpatient, telehealth-friendly schedule with no OR and minimal overnight call · long-term, longitudinal relationships with kids and families · a highly sustainable career you can do for decades, including part-time · strong job security and easy geographic mobility (demand exceeds supply almost everywhere) · a genuine, needed mission in a shortage field.

Why leave or avoid it: compensation may not reward the extra training, since three added fellowship years can yield pay near or below general pediatrics · you want procedures, acuity, or acute-care adrenaline · you dislike chronic-disease management, prior authorizations, and device/inbox administrative load · you want a research-heavy career (desirable protected-research jobs are scarce even though the field needs physician-scientists).

Best fit if: you're fascinated by hormones and feedback loops, patient by temperament, and energized by teaching families over years · you value lifestyle control and meaning and have made peace with the pay trade-off, ideally with a debt and loan-repayment plan · you want to enter a needed, accessible field where you can practice almost anywhere.

Not for you if: maximizing income is a top priority, especially with large loans and no repayment plan · you need procedural work or high-acuity variety to stay engaged · you dislike longitudinal chronic-care panels and their administrative tail.

The FLI angle — Pediatric Endocrinology for first-gen, low-income & immigrant students

Pediatric endocrinology is unusually accessible on the way in, and that's the genuinely good news.

  • Very accessible fellowship. Programs regularly underfill and competition is low, so it doesn't demand the strategic pedigree, research army, or connections that ultra-competitive fellowships do. A committed, solid applicant can get in.67
  • Comparatively open to DOs and IMGs. The field openly relies on international graduates to staff fellowship slots (~36% of 2026 applicants were non-US-MD), a real and documented entry point where the most closed fields offer none.67
  • Controllable lifestyle. Outpatient, telehealth-friendly, and minimal overnight call, which matters a lot if you're balancing family, caregiving, or being a breadwinner.3
  • Strong, durable demand. A documented national shortage and maldistribution means excellent job security and freedom to practice near family or in underserved and immigrant communities, which can also open loan-repayment and service pathways.7

The honest, important catch, named squarely: pediatric endocrinology can pay less than general pediatrics despite three additional years of fellowship.19 For an FLI student carrying significant medical-school debt, this is a central financial consideration rather than a footnote. Those three fellowship years are years of trainee-level pay and continued interest accrual, in exchange for a subspecialty income that may not exceed what you'd earn practicing general pediatrics straight out of residency. It is the field's defining structural problem; the physicians in it are organizing to fix it, but as of 2026 it remains real.

How to hold both truths, compassionately: this is a reason to go in with clear eyes and a plan rather than a reason to rule the field out. If pediatric endocrinology is what genuinely excites you, mitigate the financial side deliberately:

  • Lean on federal loan repayment / forgiveness. PSLF is very achievable given how many pediatric endocrinologists work at academic and nonprofit children's hospitals; the shortage also makes you a strong fit for shortage-area repayment programs like the NHSC.
  • The strong job market gives you negotiating leverage and the freedom to pick higher-value locations.
  • Weigh the long career horizon: a sustainable, low-burnout specialty you can practice for 30+ years has real lifetime financial and personal value that a single salary number understates.

Bottom line for FLI students: pediatric endocrinology offers an accessible door, a humane life, and desperately needed work, but it asks you to accept a pay structure that undervalues your extra training. Choose it because you love the physiology, the technology, and the families, and then protect yourself financially with a loan-repayment strategy and smart job selection. Don't choose it expecting the extra fellowship years to pay for themselves in salary alone.

Sub-subspecialty focus areas (for anyone worried it's "just diabetes")

Not formal separate boards, but distinct clinical concentrations within the field:5

  • Diabetes. The largest patient volume; type 1 and increasingly type 2; heavy technology component (CGMs, insulin pumps, closed-loop/automated insulin delivery). Some centers have dedicated diabetologists.
  • Differences/Disorders of Sex Development (DSD). Complex, multidisciplinary care (genetics, urology, surgery, psychology); intellectually demanding and relationship-intensive, sometimes urgent in newborns.
  • Bone & mineral / metabolic. Calcium, vitamin D, rickets, and rare metabolic bone disease; overlaps with genetics.
  • Obesity & metabolic disease. One of the fastest-growing areas, reshaped by adolescent GLP-1 receptor agonists; rising demand and evolving guidelines.
  • Others: growth disorders (growth-hormone therapy), thyroid (including nodule/cancer surveillance), adrenal (including congenital adrenal hyperplasia) and pituitary disorders, and gender-related care.

Fun facts

  • It is one of the few subspecialties where more training can mean similar or lower pay than the general specialty, the "more training to earn less" paradox that defines its workforce debate.9
  • Fellowship programs regularly underfill. In the appointment-year-2026 match, pediatric subspecialties as a group filled 78.3% of their positions and endocrinology filled 48.1%, making it one of the more accessible fellowships for a committed applicant.68
  • The pediatric-vs-adult endocrinology pay gap actually narrowed in 2024 (to ~26% from ~34%), partly credited to surging childhood obesity and adolescent GLP-1 use.1
  • It's one of the most technology-forward pediatric fields, since closed-loop "artificial pancreas" insulin systems and continuous glucose monitors have transformed day-to-day diabetes care.5
  • Fellows expect to spend most of their time on research/education, but reality skews heavily clinical (~75% clinical for new hires), a direct reflection of how badly the field needs bodies in clinic.7
  • Newborn "ambiguous genitalia" and DSD evaluations make it one of the few endocrine settings requiring true multidisciplinary, ethically complex, urgent consultation.5
  • Pediatric endocrinology was the 5th ABP subboard, recognized in 1978.6

Sources

Footnotes

  1. The pay paradox, national average (~$230,426 vs general pediatrics $265,230), RVU/structural drivers, academic pay below general pediatrics, adult-vs-pediatric gap (~26% in 2024 from 34%), and pediatricians' strain figures (87%/69%/65%). Doximity 2025 Physician Compensation Report (2024 data), via Op-Med/Doximity, "Despite a Small Bump in Pay, Pediatric Care Continues to Feel the Strain" (2025) (https://opmed.doximity.com/articles/despite-a-small-bump-in-pay-pediatric-care-continues-to-feel-the-strain); FierceHealthcare (2025) (https://www.fiercehealthcare.com/finance/physician-pay-sees-modest-37-bump-2024-here-are-pay-ranking-metro-area-and-specialty); JPeds/AMSPDC, "Low Compensation for Academic Pediatric Medical Specialists" (2023) (https://media.amspdc.org/wp-content/uploads/2023/09/12085008/peds-salaries-Jpeds-2023.pdf). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13

  2. "Zero to negative financial return" framing. MedMoneyGuide, Pediatrician Salary guide (2026) (https://medmoneyguide.com/guides/pediatrician-salary). Corrected 2026-08-17: a source of this kind stays with the host named rather than being removed, so the body now says MedMoneyGuide where it previously said "a 2026 compensation guide." The quoted phrase is the page's own framing rather than a measurement, and naming the aggregator lets a reader weigh it as such. The dollar figures around it come from Doximity 2025 and from peer-reviewed academic-salary work, not from here. ↩ ↩2 ↩3

  3. Scope, outpatient/longitudinal/cognitive nature, call profile, lifestyle, and satisfaction sourced from clinical work. Council of Pediatric Subspecialties (COPS), "Endocrinology" subspecialty description (accessed 2026) (https://www.pedsubs.org/about-cops/subspecialty-descriptions/endocrinology/). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11

  4. Administrative/inbox load, prior authorizations, and systemic burnout drivers. COPS (above); Op-Med/Doximity, "Despite a Small Bump in Pay…" (2025) (https://opmed.doximity.com/articles/despite-a-small-bump-in-pay-pediatric-care-continues-to-feel-the-strain). ↩ ↩2 ↩3 ↩4 ↩5

  5. Sub-focus areas (diabetes/technology, DSD, bone/metabolic, obesity/GLP-1, growth, thyroid, adrenal/pituitary, gender-related care) and the technology frontier. Compiled from COPS (above) and workforce/clinical sources; adolescent GLP-1 approvals (semaglutide, liraglutide) per FDA labeling. ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10

  6. Training pathway (3 + 3 = 6 yrs after med school), two-step entry via the NRMP Pediatric Specialties Match, ABP board (5th subboard, 1978), and 2026 SMS competitiveness (64 programs, 106 positions, 51 filled, 48.1% fill, ~56 applicants, 36 US-MD, ~0.53:1). NRMP, Results and Data: Specialties Matching Service, 2026 Appointment Year (2026) (https://www.nrmp.org/wp-content/uploads/2026/05/SMS_Results_and_Data_2026_Revised-20260522.pdf); ABP, "Pediatric Endocrinology Certification" (accessed 2026) (https://www.abp.org/subspecialties/pediatric-endocrinology); ACGME program requirements for Pediatric Endocrinology. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14

  7. Workforce shortage, reliance on IMGs, ~25% of fellows citing visa considerations, clinical-vs-research mismatch (~75% clinical for new hires; 6% research jobs), and geographic maldistribution. AAP, "Child Health Needs and the Pediatric Endocrinology Workforce: 2020–2040," Pediatrics (2024) (https://publications.aap.org/pediatrics/article/153/Supplement%202/e2023063678J/196574); Pediatrics Nationwide, "Bridging the Gap…" (2025) (https://pediatricsnationwide.org/2025/04/07/bridging-the-gap-aligning-aspirations-with-workforce-reality-in-pediatric-endocrinology/); ScienceDirect, "Understanding the Decline of the Pediatric Endocrinology Workforce…" (2025) (https://www.sciencedirect.com/science/article/pii/S1530891X25009826). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10

  8. Overall pediatric fellowship fill rate 78.3% — 1,542 of 1,969 certified positions across the 17 pediatric subspecialties, 925 programs — with endocrinology among the chronically unfilled. AAP News, "Pediatric fellowship fill rate increases to 78.3% in 2025 match" (2025) (https://publications.aap.org/aapnews/news/33913/Pediatric-fellowship-fill-rate-increases-to-78-3); NRMP, "NRMP Celebrates Results for the 2025 Medicine and Pediatric Specialties Match" (2025) (https://www.nrmp.org/about/news/2025/12/nrmp-celebrates-results-for-the-2025-medicine-and-pediatric-specialties-match/). Corrected 2026-08-17: this page read 78.3% and 48.1% as two different years, because NRMP names a match by the calendar year it is run and names its report by the appointment year the fellows start, and both labels are in circulation. They are the same match. NRMP's own release confirms it: "Among the 17 Pediatric subspecialties in the Match, 925 programs offered 1,969 certified positions, of which 1,542 positions filled at 78.3 percent," for the 2026 appointment year. This page now uses the appointment year throughout, which is the label SMS 2026 prints on its cover. ↩ ↩2

  9. "More Training to Earn Less" — pediatric subspecialists organizing on compensation/workforce reform. Medscape (2025) (https://www.medscape.com/viewarticle/more-training-earn-less-pediatric-subspecialists-band-2025a1000wdo). ↩ ↩2 ↩3 ↩4 ↩5

  10. Removed 2026-08-13. This footnote carried a median total pay figure, a base-plus-bonus split and an experience curve from Glassdoor, which is excluded under this site's compensation sourcing standard. No survey publishes any of those for this field, so nothing replaced them; the figures were deleted rather than downgraded. Corrected 2026-08-17: the dashboard and the Compensation section both said no percentiles for this field exist at all. MGMA's own Provider Specialty Roll-Ups document lists "Pediatrics: Endocrinology" as a discrete category (https://mgmatraining.com/wp-content/uploads/2025/01/ProviderSpecialtyRollUps2024.pdf), and AMGA benchmarks the same line; both sell the percentiles behind a subscription. The defensible claim is that none is published openly, which is what both places now say. The paragraph's conclusion is unchanged: with nothing free to read, you have to ask people doing the job. ↩ ↩2

  11. Removed 2026-08-13. This footnote carried an average from Marit Health / Salary.com, both excluded under this site's compensation sourcing standard. Deleted rather than downgraded. On Marit Health: it publishes a panel of self-reported physician salaries, and displays MGMA and AMGA benchmarks beside them that are masked unless you create an account. The figure quoted here comes from the self-reported panel, not from either benchmark. Read it as crowd data: unweighted, of unstated sample size, and directional. On Salary.com: its CompAnalyst benchmark is HR-reported employer survey data blended with job-posting data, not a physician panel. It is base-weighted and so runs low against total-compensation surveys, and it is used here for percentile structure rather than for levels. ↩

  12. Removed 2026-08-13. This footnote carried a ZipRecruiter figure that the page named as a low outlier and declined to use. ZipRecruiter is excluded under this site's compensation sourcing standard, so the figure is gone entirely rather than kept as a discredited comparison. ↩

  13. Academic pediatric-versus-adult compensation ratios and the wRVU mechanism. Lakshminrusimha S, Murin S, Lubarsky DA, "Low Compensation for Academic Pediatric Medical Specialists: Role of Medicaid, Productivity, Work Hours, and Sex," Journal of Pediatrics 255 (April 2023), AMSPDC, https://media.amspdc.org/wp-content/uploads/2023/09/12085008/peds-salaries-Jpeds-2023.pdf . Compensation ratios to the adult counterpart: pediatric gastroenterology 70%, pulmonology 83%, endocrinology / rheumatology / infectious disease 90%, neurology 95%, child and adolescent psychiatry 102%, pediatric anesthesia 108%, pediatric surgery 143%. Annual work-RVU benchmarks as a share of the adult counterpart: nephrology 47%, gastroenterology 56%, endocrinology 65%, surgery 76%, neurology 87%. Two limits. The paper prints no dollar figures for any specialty; its only salary values are an unlabeled scatter in Figure 1 on an axis truncated at $200,000, so nothing here can be quoted as a salary. And the underlying salaries are not raw AAMC benchmarks but "modified" ones, a three-year inflation-adjusted average under the UC Davis School of Medicine's aligned funds flow methodology, which is one institution's transform rather than a national table. The paper's text also gives pediatric surgery as 143% while its own Figure 1 shows 134%. This footnote previously carried a percentile spread, an experience curve, state-by-state ranges, a wRVU conversion factor, a weekly-hours figure and two satisfaction percentages from SalaryDr (n=25), which is excluded under this site's compensation sourcing standard. All of it was removed rather than downgraded on 2026-08-13. ↩ ↩2

  14. Pediatrics remains lowest-paying specialty; ~47% expect flat pay, 45% feel fairly compensated; general pediatrics ~$266k. Medscape Pediatrician Compensation Report 2026, via Nuaxia (2026) (https://www.nuaxia.com/post/medscape-pediatrician-compensation-report-2026). ↩

  15. Telehealth leadership in endocrinology. Endocrine Society, "Appropriate Use of Telehealth Visits in Endocrinology," PMC (2023) (https://pmc.ncbi.nlm.nih.gov/articles/PMC10233476/); Endocrine Society, "Perspective: Telehealth in Endocrinology" (https://www.endocrine.org/journals/jcem/telehealth-in-endocrinology). ↩

  16. Cross-specialty burnout benchmarks: pediatrics 51%, endocrinology 44%. Medscape Physician Burnout & Depression Report 2024 (n=9,226, fielded July–October 2023), against an all-physician average of 49%. That report is paywalled and returns HTTP 402, so its specialty rows are read through three independent relays that agree on the edition, the instrument and every row: Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) and Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout). Pediatric endocrinology is not broken out separately in that report, so the two parent figures are directional context rather than a measurement of this subspecialty. ⟳ ↩ ↩2

  17. Women among pediatric endocrinology fellows. ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21 (Number of Active Residents by Specialty and Subspecialty and Sex), https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf — pediatric endocrinology: 72 programs, 252 active fellows, 196 women (77.8%), 45 men (17.9%), 11 not reported (4.4%). Pediatrics itself is 74.8%, and all active residents and fellows are 49.5%. The pediatrics subspecialty rows above it are pediatric transplant hepatology 86.7%, developmental-behavioral pediatrics 86.0%, pediatric hospital medicine 82.6%, pediatric rheumatology 80.2%, child abuse pediatrics 79.6% and adolescent medicine 78.6%. ⟳ Corrected 2026-08-17. This page estimated "around 70–75%+ women" and told the reader the exact figure lived in the ABP interactive dashboard. It is published, in a free PDF, in a table two sibling profiles already cite, and it is 77.8% — above the band the page guessed. The two figures the page did cite, ~72% of entering fellows in 2013 and ~75% of applicants in 2014, are adult endocrinology and are a decade old; they are kept for the adult trend and no longer stand in for this subspecialty. The comparative claim was right and survives. ↩

  18. Endocrinology trending strongly female (~72% entering fellows 2013; ~75% applicants 2014; projected female-predominant). JCEM, "Female Physicians and the Future of Endocrinology" (2016) (https://academic.oup.com/jcem/article/101/1/16/2806435); MedCentral (https://www.medcentral.com/endocrinology/endocrinology-predicted-become-female-predominant-specialty). ↩

  19. Pediatrics ~75% female among trainees. Superseded for the subspecialty figure itself by 17, which is measured. AAP, "Confronting Gender Disparities in the Pediatric Workforce" (https://www.aap.org/en/news-room/aap-voices/confronting-gender-disparities-in-the-pediatric-workforce-and-fighting-for-change/); ABP "Pediatric Subspecialists Ever Certified" dashboard (https://www.abp.org/research/pediatric-subspecialties-1961). ↩

  20. Synthesized online sentiment (pay-paradox debate, accessibility, workforce shortage, warm defense by those in it) — paraphrased recurring themes, no verbatim quotes. r/pediatrics, r/medicalschool, Student Doctor Network. ↩

  21. Mission/ethos of pediatric diabetes care. KevinMD, "Why type 1 diabetes screening should be part of back-to-school" (2025) (https://kevinmd.com/2025/09/why-type-1-diabetes-screening-should-be-part-of-back-to-school.html). ↩

Researched with AI assistance and reviewed by hand. How this site is made